MT 1668 2,6-Diaminopurine dioxolane, [5'-3H]-
|
(DAPD,
[5'-3H]-) |
MORpure™ HPLC Purified,
Delivered ≥ 97% pure with dated HPLC radiochromatogram |
Ethanol:water (1:1) solution,
1 mCi/ml |
> 5 Ci(185 GBq)/mmol |
Please
Inquire for Pricing |
NextGen V-Vial - shipped on dry ice |
M.W. 252.23 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
MT 1687 (-)-β-D-2,6-Diaminopurine dioxolane, [8-3H]-
|
((-)-DAPD,
[8-3H]-) |
MORpure™ HPLC Purified,
Delivered ≥ 97% pure with dated HPLC radiochromatogram |
Ethanol:water (1:1) solution,
1 mCi/ml |
> 1 Ci(37
GBq)/mmol |
50 μCi (1.85
MBq) $1160 |
NextGen V-Vial - shipped on dry ice |
250 μCi
(9.25 MBq)
$1970 |
M.W. 252.23 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
MT 1821 2,6-Diaminopurine riboside, [8-3H(N)]-
|
MORpure™ HPLC Purified,
Delivered ≥ 97% pure with dated HPLC radiochromatogram |
Ethanol:water (1:1) solution,
1 mCi/ml |
> 5 Ci(185 GBq)/mmol |
Please
Inquire for Pricing |
NextGen V-Vial - shipped on dry ice |
M.W. 282.3 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |